Radiolabeled hTAB004 (Imaging)
Breast Cancer, Pancreatic Cancer
PreclinicalActive
Key Facts
About OncoTAb
OncoTAb is a private, pre-revenue biotech company leveraging its patented tMUC1-targeting antibody platform to address unmet needs in oncology. Its initial focus is the commercial launch of the Agkura Personal Score, a blood-based diagnostic test for breast cancer detection in women with dense breasts, which represents a significant market opportunity. Beyond diagnostics, the company has a preclinical pipeline exploring the same targeting agent for therapeutic applications, including radioimmunotherapy and CAR-T cell therapies for breast and pancreatic cancers.
View full company profileTherapeutic Areas
Other Breast Cancer, Pancreatic Cancer Drugs
| Drug | Company | Phase |
|---|---|---|
| Complex Generic Oncology Injectables | Cipla | ANDA Filed/Approved |